Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition

International Journal of Impotence Research

Volumn 18, Issue 3, 2006, Pages 258-263

  Nangle, M R ^a   Cotter, Ma ^a   Cameron, N E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Corpus cavernosum; Diabetes; Endothelium; Neuropathy; Nitric oxide; p38 mitogen activated protein kinase; Smooth muscle

Indexed keywords

ACETYLCHOLINE; LY 2161793; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE DONOR; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVE; AUTONOMIC NEUROPATHY; BLOOD VESSEL FUNCTION; CORPUS CAVERNOSUM; DIABETIC NEUROPATHY; ENDOTHELIUM DEPENDENT RELAXATION; ENDOTHELIUM INDEPENDENT RELAXATION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; MALE; MOUSE; NERVE FUNCTION; NEUROVASCULAR DYSFUNCTION; NITRERGIC NERVE; NONHUMAN; PENILE BLOOD VESSEL; PENILE NEUROVASCULAR FUNCTION; PENIS; PRIORITY JOURNAL; SMOOTH MUSCLE; STREPTOZOCIN DIABETES; STRESS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PENIS; PROTEIN KINASE INHIBITORS; STREPTOZOCIN;

EID: 33646544053     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901414     Document Type: Article

References (36)

1. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-1988.
2. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622.
3. Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJM, Fernyhough P et al. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001; 15: 2508-2514.
4. Giuliano F, Rampin O. Neural control of erection. Physiol Behav 2004; 83: 189-201.
5. Azadzoi KM, de Tejada IS. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1992; 148: 1587-1591.
6. Gocmen C, Secilmis A, Kumcu EK, Ertug PU, Onder S, Dikmen A et al. Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur J Pharmacol 2000; 398: 93-98.
7. Nangle MR, Cotter MA, Cameron NE. Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Diabetes 2003; 52: 2396-2402.
8. de Tejada IS, Goldstein I, Azadzoi KM, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025-1030.
9. Price SA, Agthong S, Middlemas AB, Tomlinson DR. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes 2004; 53: 1851-1856.
10. Sweitzer SM, Medicherla S, Almirez R, Dugar S, Chakravarty S, Shumilla JA et al. Antinociceptive action of a p38α MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 2004; 109: 409-419.
11. McGinn S, Saad S, Poronnik P, Pollock CA. High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol 2003; 285: E708-E717.
12. Azuma N, Akasaka N, Kito H, Ikeda M, Gahtan V, Sasajima T et al. Role of p38 MAP kinase in endothelial cell alignment induced by fluid shear stress. Am J Physiol 2001; 280: H189-H197.
13. De Dios A, Shih C, Lopez de Uralde B, Sanchez C, del Prado M, Martin Cabrejas LM et al. Design of potent and selective 2-aminobenzimidazole-based p38a MAP kinase inhibitors with excellent in vivo efficacy. J Med Chem 2005; 48: 2270-2273.
14. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S et al. Amelioration of accelerated diabetic mesangila expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000; 14: 439-447.
15. Nangle MR, Cotter MA, Cameron NE. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur J Pharmacol 2003; 475: 99-106.
16. Johnstone MT, Creager BSN, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510-2516.
17. McVeigh SE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 771-776.
18. Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidant, α-lipoic acid, on endothelial and neurogenic functions of corpus cavernosum in rats. Diabetologia 1999; 42: 343-350.
19. Nangle MR, Cotter MA, Cameron NE. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol 2004; 502: 143-148.
20. Thompson CS, Mumtaz FH, Khan MA, Wallis RM, Mikhailidis DP, Morgan RJ et al. The effect of sildenafil on corpus cavernosum smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit. Eur J Pharmacol 2001; 425: 57-64.
21. Way KJ, Reid JJ. The effects of diabetes on nitric oxide-mediated responses in rat corpus cavernosum. Eur J Pharmacol 1999; 376: 73-82.
22. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999; 103: 185-195.
23. van Etten RW, de Koning EJ, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ. Intensive lipid lowering by statin therapy does not improve vascular reactivity in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2002; 22: 799-804.
24. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction. Diabetes Obes Metab 2002; 4: 224-238.
25. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424-C1437.
26. Srinivasan S, Bolick DT, Hatley ME, Natarajan R, Reilly KB, Yeh M et al. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem 2004; 279: 31930-31936.
27. Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M. High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem Biophys Bes Commun 2003; 305: 122-128.
28. Sommer F, Klotz T, Steinritz D, Schmidt A, Addicks K, Engelmann U et al. MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum. Int J Impot Res 2002; 14: 217-225.
29. Hoefen RJ, Berk BC. The role of MAP kinases in endothelial activation. Vasc Pharmacol 2002; 38: 271-273.
30. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA 2002; 99: 4061-4066.
31. Archibald V, Cotter MA, Keegan A, Cameron NE. Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn-Schmeideberg's Arch Pharmacol 1996; 353: 584-591.
32. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
33. Cameron NE, Nangle MR, Gibson TM, Cotter MA. Benfotiamine treatment improves vascular endothelium and nerve function in diabetic rats. Diabetes 2004; 53: A35.
34. Gibson TM, Cotter MA, Cameron NE. Effects of α-lipoic acid on impaired gastric fundus innervation in diabetic rats. Free Radic Biol Med 2003; 35: 160-168.
35. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-2362.
36. Cameron NE, Cotter MA. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J Diabetes Complications 2001; 15: 198-202.